These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6421104)

  • 1. Haemostatic function and ischaemic heart disease.
    Meade TW
    Adv Exp Med Biol; 1984; 164():3-9. PubMed ID: 6421104
    [No Abstract]   [Full Text] [Related]  

  • 2. An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group.
    Meade TW; Stirling Y; Thompson SG; Vickers MV; Woolf L; Ajdukiewicz AB; Stewart G; Davidson JF; Walker ID; Douglas AS
    Int J Epidemiol; 1986 Sep; 15(3):331-6. PubMed ID: 3095254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostatic function and cardiovascular death: early results of a prospective study.
    Meade TW; North WR; Chakrabarti R; Stirling Y; Haines AP; Thompson SG; Brozovié M
    Lancet; 1980 May; 1(8177):1050-4. PubMed ID: 6103391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostatic changes after heart transplantation and their relationship to accelerated coronary sclerosis.
    Hunt BJ; Segal H; Yacoub M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1233-5. PubMed ID: 1899158
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of hemostatic markers in the pathogenesis of coronary diseases].
    Russo C
    Recenti Prog Med; 2002 Feb; 93(2):75-7. PubMed ID: 11887348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic factors and coronary heart disease.
    Lancet; 1981 Jan; 1(8210):22-3. PubMed ID: 6109053
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
    Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD
    Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal status and haemostatic variables.
    Meade TW; Haines AP; Imeson JD; Stirling Y; Thompson SG
    Lancet; 1983 Jan; 1(8314-5):22-4. PubMed ID: 6129369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic changes that constitute the hypercoagulable state.
    Miller GJ; Wilkes HC; Meade TW; Bauer KA; Barzegar S; Rosenberg RD
    Lancet; 1991 Oct; 338(8774):1079. PubMed ID: 1681380
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
    Meade TW; Mellows S; Brozovic M; Miller GJ; Chakrabarti RR; North WR; Haines AP; Stirling Y; Imeson JD; Thompson SG
    Lancet; 1986 Sep; 2(8506):533-7. PubMed ID: 2875280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity and clotting factors in ischaemic heart disease in women.
    Meade TW; Cooper JA; Chakrabarti R; Miller GJ; Stirling Y; Howarth DJ
    BMJ; 1996 Jun; 312(7046):1581. PubMed ID: 8664669
    [No Abstract]   [Full Text] [Related]  

  • 12. Variation between batches in clotting factor assays.
    North WR; Stirling Y; Meade TW
    Thromb Haemost; 1982 Dec; 48(3):274-6. PubMed ID: 6819647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VII and ischaemic heart disease: epidemiological evidence.
    Meade TW
    Haemostasis; 1983; 13(3):178-85. PubMed ID: 6350123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of exercise capacity and sedentary lifestyle on haemostasis among middle-aged women with coronary heart disease.
    Nagy E; Janszky I; Eriksson-Berg M; Al-Khalili F; Schenck-Gustafsson K
    Thromb Haemost; 2008 Nov; 100(5):899-904. PubMed ID: 18989536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemostasis in the guinea pig and its natural hypothrombinemia].
    Mayer G; Selva J; Mayer S; Waitz R
    Pathol Biol; 1965 Nov; 13(21):1009-15. PubMed ID: 4875794
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study.
    Salomaa V; Rasi V; Pekkanen J; Vahtera E; Jauhiainen M; Vartiainen E; Myllylä G; Ehnholm C
    Eur Heart J; 1994 Oct; 15(10):1293-9. PubMed ID: 7821305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic factors and coronary heart disease.
    Lancet; 1981 Jun; 1(8232):1266-7. PubMed ID: 6112594
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemostatic factors and ischaemic heart disease. The Caerphilly study.
    Yarnell JW; Sweetnam PM; Elwood PC; Eastham R; Gilmour RA; O'Brien JR; Etherington MD
    Br Heart J; 1985 May; 53(5):483-7. PubMed ID: 3994861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic factors and risk of coronary heart disease.
    De Lorenzo F; Kadziola Z; Kakkar VV
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):113-4. PubMed ID: 10192662
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertriglyceridaemia and hypercoagulability.
    Simpson HC; Mann JI; Meade TW; Chakrabarti R; Stirling Y; Woolf L
    Lancet; 1983 Apr; 1(8328):786-90. PubMed ID: 6132131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.